Key points are not available for this paper at this time.
These results indicate that markers of systemic inflammation confer a statistically significant additional risk for cardiovascular death among patients with RA, even after controlling for traditional cardiovascular risk factors and comorbidities.
Kremers et al. (Tue,) studied this question.